306, 2016

Developing RDTs to tackle tropical diseases

Atomo is delighted to announce that the company has secured  $1.38 million in grant funding from the Australian Government to assist in the development and commercialisation of new rapid tests for the detection of dengue and [...]

306, 2016

Atomo Diagnostics Makes Waves on Sky News

Atomo’s CEO describes the company’s innovations in rapid diagnostics on Sky News Atomo Group CEO, John Kelly, was invited to talk with Peter Switzer on Sky News on 25 July 2016 to discuss the company’s [...]

1301, 2016

US$6M investment from GHIF supports Atomo’s scale up

Atomo Diagnostics has today received a US$6 million [A$8.5 million] loan from a the Global Health Investment Fund (GHIF)  to support the scale-up of production operations and expansion of commercial activities related to the AtomoRapid™ rapid [...]

2711, 2015

Awarded A$1.8 grant to develop HIV Self-Test

 Atomo Diagnostics is delighted to announce that the company has been awarded a grant of A$1.8 million (US$1.3M) from the New South Wales Medical Device Fund 2015-2016 for the development of a self-test for rapid [...]